Combination therapy method for treating chronic hepatitis B
AssigneeSciClone Pharmaceuticals, Inc.
InventorDavid L. Horwitz
Life of this patent
Estimating the term…
Abstract
The present invention is aimed at augmenting the success rate of using thymosin in treatment of chronic hepatitis B, by employing a combination therapy using thymosin with antiviral agents which are effective in inhibiting DNA synthesis or DNA polymerase during replication of the hepatitis B virus.
Claims21
A method for treating chronic hepatitis B infection in mammals comprising concurrently administering to a subject having chronic hepatitis B a therapeutically effective amount of at least one thymosin, and an inhibitorily effective amount of at least one hepatitis B virus replication or DNA polymerase inhibitor compound, either free or as a pharmaceutically acceptable salt, in a pharmaceutically acceptable vehicle.
Dependencies are inferred from the claim text.